Calibre Post Acute: Care Quality Deficiencies - NM
The November 2025 inspection, triggered by a complaint, found that the facility had no care plan entries directing staff to monitor the resident, identified in records as Resident 16, for worsening depression, suicidal thinking, or suicidal behavior. His medications, escitalopram and trazodone, both carried explicit warnings requiring close monitoring. Neither warning translated into any documented instruction for the people caring for him.
A licensed practical nurse told inspectors that Resident 16 had not been monitored for suicidal thoughts, had not been monitored for depression symptoms, and had no non-pharmacological interventions in place for his depression diagnosis. Staff were, however, monitoring him for something else: inappropriate sexual behaviors toward female staff and female residents.
The director of nursing confirmed each gap during an interview on October 10. The care plan did not include the specific behaviors staff should watch for. It did not include non-pharmacological interventions. It did not direct staff to monitor for clinical worsening or the emergence of suicidal thoughts. The director acknowledged that the care plan should have captured both the interventions in place and the behaviors staff were expected to track.
CMS rated the deficiency as minimal harm or potential for actual harm.
What the care plan reflected was a resident being managed for one set of behavioral concerns while the warnings attached to his own psychiatric medications went unaddressed. Whether anyone ever asked Resident 16 how he was doing, the inspection record does not say.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Calibre Post Acute, LLC from 2025-11-18 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 4, 2026 · Our methodology
Calibre Post Acute, LLC in Las Cruces, NM was cited for violations during a health inspection on November 18, 2025.
His medications, escitalopram and trazodone, both carried explicit warnings requiring close monitoring.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.